• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zentalis Pharmaceuticals Inc (NQ: ZNTL )

    3.955 +0.145 (+3.81%)
    Streaming Delayed Price Updated: 12:10 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Zentalis Pharmaceuticals Inc

    < Previous 1 2 3 Next >
    FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
    The FDA has lifted the partial clinical hold on Zentalis Pharmaceuticals' azenosertib studies. Zentalis plans to work with trial investigators to continue development while presenting additional data... 
    Via Benzinga
    Exposures Product Safety
    Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL
    From Newman Ferrara LLP
    Via Business Wire
    Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    (ZNTL) - Analyzing Zentalis Pharma's Short Interest
    Via Benzinga
    Analyst Expectations for Zentalis Pharma's Future
    Via Benzinga
    Where Zentalis Pharma Stands With Analysts
    Via Benzinga
    Analyst Expectations for Zentalis Pharma's Future
    Via Benzinga
    ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024
    ZNTL stock results show that Zentalis Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Wall Street's Top 10 Stock Calls This Week - Saturday, June 22
    What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024. 
    Via Talk Markets
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes
    Via Benzinga
    Where Zentalis Pharma Stands With Analysts
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
    Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths. 
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024
    ZNTL stock results show that Zentalis Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
    MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. 
    Via Talk Markets
    Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
    From Immunome, Inc.
    Via Business Wire
    Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
    U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
    Although US stocks closed lower on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More
    Via Benzinga
    Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to... 
    Via Benzinga
    Why Shares of Zentalis Pharmaceuticals Dropped This Week
    A rash of insider selling meant the stock gave back some of its gains from last week. 
    Via The Motley Fool
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.